coumarin has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies
2H-chromen-2-one: coumarin derivative
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with ischemic stroke or transient ischemic attack presumably related to patent foramen ovale (PFO) are at risk for recurrent cerebrovascular events." | 1.38 | Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. ( Geister, L; Jüni, P; Kalesan, B; Mattle, HP; Meier, B; Mono, ML; Nedeltchev, K; Praz, F; Räber, L; Wahl, A; Windecker, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wahl, A | 1 |
| Jüni, P | 1 |
| Mono, ML | 1 |
| Kalesan, B | 1 |
| Praz, F | 1 |
| Geister, L | 1 |
| Räber, L | 1 |
| Nedeltchev, K | 1 |
| Mattle, HP | 1 |
| Windecker, S | 1 |
| Meier, B | 1 |
| Schipper, JP | 1 |
2 other studies available for coumarin and Anterior Circulation Transient Ischemic Attack
| Article | Year |
|---|---|
Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
Topics: Adult; Anticoagulants; Cardiac Catheterization; Cardiovascular Diseases; Case-Control Studies; Couma | 2012 |
[Consensus on antithrombotic prophylaxis of vascular events in patients with manifested atherosclerotic vascular disease].
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Cou | 1998 |